Short-term energy restriction reduces resting energy expenditure in patients with HIV lipodystrophy and hypermetabolism

Metabolism: Clinical and Experimental

Volumn 56, Issue 2, 2007, Pages 289-295

  Kosmiski, Lisa A ^a,b   Bessesen, Daniel H ^a,b   Stotz, Sarah A ^a   Koeppe, John R ^a   Horton, Tracy J ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; DIET RESTRICTION; DIETARY INTAKE; ENERGY; ENERGY CONSUMPTION; ENERGY EXPENDITURE; FEMALE; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERMETABOLISM; LEAN BODY WEIGHT; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADIPOSE TISSUE; BODY COMPOSITION; BODY MASS INDEX; CALORIC RESTRICTION; CALORIMETRY, INDIRECT; ENERGY METABOLISM; FEMALE; HIV INFECTIONS; HUMANS; LIPODYSTROPHY; MALE; MIDDLE AGED; PULMONARY GAS EXCHANGE;

EID: 33846056466     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.10.012     Document Type: Article

References (33)

1. Carr A., Samaras K., Burton S., et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12 (1998) F51-F58
2. Wanke C.A. Epidemiological and clinical aspects of the metabolic complications of HIV infection. The fat redistribution syndrome. AIDS 13 (1999) 1287-1293
3. Kosmiski L.A., Kuritzkes D.R., Lichtenstein K.A., et al. Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome. AIDS 15 (2001) 1993-2000
4. Dube M.P., Edmondson-Melancon H., Qian D., et al. Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients. JAIDS 27 (2001) 130-134
5. Purnell J.Q., Zambon A., Knopp R.H., et al. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS 14 (2000) 51-57
6. Kosmiski L.A., Kuritzkes D.R., Sharp T.A., et al. Total energy expenditure and carbohydrate oxidation are increased in the human immunodeficiency virus lipodystrophy syndrome. Metabolism 52 (2003) 620-625
7. Rossini A.A., Self J., Aoki T.T., et al. Metabolic and endocrine studies in a case of lipoatrophic diabetes. Metabolism 26 (1977) 637-650
8. Klein S., Jahoor F., Wolfe R.R., et al. Generalized lipodystrophy: in vivo evidence for hypermetabolism and insulin-resistant lipid, glucose and amino acid kinetics. Metabolism 41 (1992) 893-896
9. Seip M., and Trygstad O. Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl 413 (1996) S2-S28
10. Kobberling J., Willms B., Kattermann R., et al. Lipodystrophy of the extremities: a dominantly inherited syndrome associated with lipoatrophic diabetes. Humangenetik 29 (1975) 111-120
11. Cutler D.L., Kaufmann S., and Freidenberg G.R. Insulin-resistant diabetes mellitus and hypermetabolism in mandibuloacral dysplasia: a newly recognized form of partial lipodystrophy. J Clin Endocrinol Metab 73 (1991) 1056-1061
12. Johansen K., Rasmussen M.H., Kjems L.L., et al. An unusual type of familial lipodystrophy. J Clin Endocrionol Metab 80 (1995) 3442-3446
13. Ross S.R., Graves R.A., and Speigelman B.M. Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity. Genes Dev 7 (1993) 1318-1324
14. Moitra J., Mason M.M., Olive M., et al. Life without fat: a transgenic mouse. Genes Dev 12 (1998) 3168-3181
15. Harris J.A., and Benedict F.G. A biometric study of basal metabolism in man (1919), Carnegie Institute of Washington, Washington (DC)
16. Weir J.B.V. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109 (1949) 1-9
17. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
18. Kosmiski L., Kuritzkes D., Hamilton J., et al. Fat distribution is altered in HIV-infected men without clinical evidence of the HIV lipodystrophy syndrome. HIV Med 4 (2003) 235-240
19. Bacchetti P., Gripshover B., Grunfeld C., et al. Fat redistribution in men with HIV infection: from the Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). J Acquir Immune Defic Syndrome 40 (2005) 121-131
20. Sekhar R.V., Jahoor F., White A.C., et al. Metabolic basis of the HIV-lipodystrophy syndrome. Am J Physiol Endocrinol Metab 283 (2002) E332-E337
21. Renard E., Fabre J., Paris F., et al. Syndrome of body fat redistributionn in HIV-1-infected patients: relationships to cortisol and catecholamines. Clin Endocrinol 51 (1999) 223-230
22. Savage D.S., Murgatroyd P.R., Chatterjee V.K., et al. Energy expenditure and adaptive responses to an acute caloric load in humans with lipodystrophy. J Clin Endocrinol Metab 90 (2005) 1446-1452
23. Goldstone A.P., Thomas E.L., Brynes A.E., et al. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab 86 (2001) 4330-4338
24. Mori Y., Murakawa Y., Okada K., et al. Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care 22 (1999) 908-912
25. Weber R.V., Buckley M.C., Fried S.K., et al. Subcutaneous lipectomy causes a metabolic syndrome in hamsters. Am J Physiol Regul Integr Comp Physiol 279 (2000) R936-R943
26. Happ M., Siewecke C., Thamer C., et al. Multiple symmetric lipomatosis: a paradigm of metabolically innocent obesity?. Diabetes Care 27 (2004) 794-795
27. Luzi L., Perseghin G., Tambussi G., et al. Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy. Am J Physiol Endocrinol Metab 284 (2003) E274-E280
28. Gan S.K., Samaras K., Thompson C.H., et al. Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. Diabetes 51 (2002) 3161-3169
29. Horton T.J., and Hill J.O. Prolonged fasting significantly changes nutrient oxidation and glucose tolerance after a normal mixed meal. J Appl Physiol 90 (2001) 155-163
30. Robbins D.C., Danforth E., Horton E.S., et al. The effect of diet on thermogenesis in acquired lipodystrophy. Metabolism 28 (1979) 908-916
31. Oral E.A., Simha V., Ruiz E., et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 346 (2002) 570-578
32. Savage D.B., Murgatroyd P.R., Chatterjee V.K., et al. Energy expenditure and adaptive responses to an acute hypercaloric fat load in humans with lipodystrophy. J Clin Endocrinol Metab 90 (2004) 1446-1452
33. Roberts S.B., and Rosenberg I. Nutrition and aging: changes in the regulation of energy metabolism with aging. Physiol Rev 86 (2006) 651-667